Formulation and Evaluation of Eudragit RL-100 Nanoparticles Loaded In-Situ Forming Gel for Intranasal Delivery of Rivastigmine

• Asıl Yazarlar: Sara Salatin (Yazar), Jaleh Barar (Yazar), Mohammad Barzegar-Jalali (Yazar), Khosro Adibkia (Yazar), Mitra Alami-Milani (Yazar), Mitra Jelvehgari (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Tabriz University of Medical Sciences, 2020-01-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Purpose: Rivastigmine hydrogen tartrate (RHT) is commonly used for the treatment of mild to moderate Alzheimer's disease (AD). The aim of this work was to formulate in-situ pluronic F-127 (PF-127) hydrogels containing Eudragit RL-100 (EU-RL) nanoparticles (NPs) in order to improve the therapeut...